The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus

Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions are urgently required. Cathelicidins are cationic host defence peptides expressed in the inflamed lung, with key roles in innate host defence against infection. We demonstrate that the human cathelicidin LL-37 has effective antiviral activity against RSV in vitro, retained by a truncated central peptide fragment. LL-37 prevented virus-induced cell death in epithelial cultures, significantly inhibited the production of new infectious particles and diminished the spread of infection, with antiviral effects directed both against the viral particles and the epithelial cells. LL-37 may represent an important targetable component of innate host defence against RSV infection. Prophylactic modulation of LL-37 expression and/or use of synthetic analogues post-infection may represent future novel strategies against RSV infection.

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  D. Davidson,et al.  Cationic Host Defence Peptides: Potential as Antiviral Therapeutics , 2013, BioDrugs.

[3]  Divyendu Singh,et al.  The Human Antimicrobial Peptide LL-37, but Not the Mouse Ortholog, mCRAMP, Can Stimulate Signaling by Poly(I:C) through a FPRL1-dependent Pathway* , 2013, The Journal of Biological Chemistry.

[4]  D. Davidson,et al.  LL-37: An Immunomodulatory Antimicrobial Host Defence Peptide , 2013 .

[5]  K. Hartshorn,et al.  The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. , 2013, The Journal of general virology.

[6]  M. Neuman,et al.  Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. , 2012, The Journal of allergy and clinical immunology.

[7]  L. Lindbom,et al.  Induction of the human cathelicidin LL‐37 as a novel treatment against bacterial infections , 2012, Journal of leukocyte biology.

[8]  S. Wenzel,et al.  Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma , 2012, Nature Medicine.

[9]  C. Scagnolari,et al.  Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus , 2012, Medical Microbiology and Immmunology.

[10]  D. Davidson,et al.  Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37 , 2011, PloS one.

[11]  K. Bhardwaj,et al.  LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs , 2011, PloS one.

[12]  E. Hyppönen,et al.  Vitamin D status has a linear association with seasonal infections and lung function in British adults , 2011, British Journal of Nutrition.

[13]  J. Andersson,et al.  Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy , 2011, PloS one.

[14]  M. Rovers,et al.  Cord Blood Vitamin D Deficiency Is Associated With Respiratory Syncytial Virus Bronchiolitis , 2011, Pediatrics.

[15]  C. Cho,et al.  Effects of cathelicidin and its fragments on three key enzymes of HIV-1 , 2011, Peptides.

[16]  C. Richardson,et al.  Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread , 2011, Journal of Virology.

[17]  J. Oxford,et al.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus. , 2010, American journal of respiratory and critical care medicine.

[18]  P. DePetrillo,et al.  Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults , 2010, PloS one.

[19]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[20]  J. Schwarze,et al.  Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology , 2010, Clinical Microbiology Reviews.

[21]  T. S. Wilkinson,et al.  The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. , 2010, American journal of respiratory cell and molecular biology.

[22]  J. Steinmann,et al.  Phenylbutyrate Induces Antimicrobial Peptide Expression , 2009, Antimicrobial Agents and Chemotherapy.

[23]  L. Foster,et al.  Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes1 , 2009, The Journal of Immunology.

[24]  C. Haslett,et al.  Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages , 2009, Journal of leukocyte biology.

[25]  R. Gallo,et al.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. , 2009, Trends in immunology.

[26]  G. Hunninghake,et al.  Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.

[27]  Y. Xiang,et al.  Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus* , 2008, Journal of Biological Chemistry.

[28]  P. Dhawan,et al.  Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[29]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[30]  J. Söderlund,et al.  The antimicrobial peptide LL-37 inhibits HIV-1 replication. , 2007, Current HIV research.

[31]  Guangshun Wang,et al.  Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. , 2006, Journal of the American Chemical Society.

[32]  J. J. Grote,et al.  Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application , 2006, Peptides.

[33]  Fiona S. L. Brinkman,et al.  Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-371 , 2006, The Journal of Immunology.

[34]  R. Hancock,et al.  Immunomodulatory Properties of Defensins and Cathelicidins , 2006, Current topics in microbiology and immunology.

[35]  H. Koeffler,et al.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  E. Walsh,et al.  Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.

[37]  Robert E W Hancock,et al.  A re-evaluation of the role of host defence peptides in mammalian immunity. , 2005, Current protein & peptide science.

[38]  Ling C. Huang,et al.  Human Cathelicidin (LL-37), a Multifunctional Peptide, is Expressed by Ocular Surface Epithelia and has Potent Antibacterial and Antiviral Activity , 2005, Current eye research.

[39]  R. Hancock,et al.  Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells , 2005, Infection and Immunity.

[40]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.

[41]  U. Wahn,et al.  β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis , 2004 .

[42]  U. Wahn,et al.  Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[43]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[44]  R. Bals,et al.  Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. , 2002, American journal of respiratory and critical care medicine.

[45]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[46]  L. Chin,et al.  CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[47]  M. Cannon.  Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. , 1987, Journal of virological methods.

[48]  J. Melnick,et al.  Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) , 1968, Journal of virology.

[49]  Hambling Mh.  SURVIVAL OF THE RESPIRATORY SYNCYTIAL VIRUS DURING STORAGE UNDER VARIOUS CONDITIONS. , 1964 .

[50]  M. Hambling.  SURVIVAL OF THE RESPIRATORY SYNCYTIAL VIRUS DURING STORAGE UNDER VARIOUS CONDITIONS. , 1964, British journal of experimental pathology.